Publication Date
In 2025 | 0 |
Since 2024 | 2 |
Descriptor
Foreign Countries | 2 |
Pharmacology | 2 |
Acquired Immunodeficiency… | 1 |
Attitudes | 1 |
Autism Spectrum Disorders | 1 |
Children | 1 |
Drug Therapy | 1 |
Epilepsy | 1 |
Ethics | 1 |
Feedback (Response) | 1 |
Genetics | 1 |
More ▼ |
Author
Adelline Twimukye | 1 |
Aine Roddy | 1 |
Bethany Oakley | 1 |
Catriona Waitt | 1 |
Celso Arango | 1 |
David Kyaddondo | 1 |
Declan Murphy | 1 |
Erisa S Mwaka | 1 |
Ian Guyton Munabi | 1 |
James Cusack | 1 |
Maria Andreina Mendez | 1 |
More ▼ |
Publication Type
Journal Articles | 2 |
Reports - Research | 2 |
Education Level
Audience
Location
Ireland | 1 |
Italy | 1 |
Spain | 1 |
Uganda | 1 |
United Kingdom (England) | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Michela Tinelli M; Aine Roddy; Martin Knapp; Celso Arango; Maria Andreina Mendez; James Cusack; Declan Murphy; Roberto Canitano; Bethany Oakley; Vinciane Quoidbach – Journal of Autism and Developmental Disorders, 2024
We examine the cost-effectiveness of treating epilepsy with anti-epileptic medicines in autistic children, looking at impacts on healthcare providers (in England, Ireland, Italy and Spain) and children's families (in Ireland). We find carbamazepine to be the most cost-effective drug to try first in children with newly diagnosed focal seizures. For…
Descriptors: Foreign Countries, Autism Spectrum Disorders, Epilepsy, Pharmacology
Sylvia Nabukenya; David Kyaddondo; Adelline Twimukye; Ian Guyton Munabi; Catriona Waitt; Erisa S Mwaka – Research Ethics, 2024
This study aimed to explore stakeholders' perspectives on the ethical considerations for returning individual pharmacogenomics research results to people living with HIV. A qualitative approach to investigation involved five focus group discussions with 30 Community representatives, 12 key informant interviews with researchers, and 12 in-depth…
Descriptors: Foreign Countries, Acquired Immunodeficiency Syndrome (AIDS), Pharmacology, Genetics